# A Study of BEBT-209 Plus Chemotherapy in Patients With Locally Advanced or Metastatic Triple-Negative Breast Cancer

> clinical trial · VERIFIED · 2026-08-18

Status: RECRUITING · Sponsor: BeBetter Med Inc · Condition: Locally Advanced Triple-negative Breast Cancer

- Company: BeBetter Med Inc
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07544056

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.